| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |